Page last updated: 2024-12-07

cholesteryl octanoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cholesteryl octanoate is an ester of cholesterol and octanoic acid. It is a white, crystalline solid that is insoluble in water but soluble in organic solvents. Cholesteryl octanoate is found in small amounts in animal tissues, and it has been shown to have a number of biological effects. For example, it has been shown to inhibit the growth of certain types of cancer cells. Cholesteryl octanoate is also a component of the cell membrane, and it may play a role in the regulation of cell signaling. The compound is studied for its potential therapeutic applications, particularly in cancer treatment. Research is ongoing to understand its effects on cell proliferation, differentiation, and apoptosis. Its importance lies in its potential to serve as a novel therapeutic agent for cancer and other diseases.'

cholesteryl octanoate: used for breath tests for detection of pancreatic insufficiency in rats [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID102015
SCHEMBL ID161053
MeSH IDM0152126

Synonyms (35)

Synonym
cholesteryl caprylate
1182-42-9
cholesterol n-octanoate
n-octanoic acid cholesterol ester
cholesteryl n-octanoate
cholesteryl octanoate
[(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] octanoate
x9u26ha4z2 ,
cholest-5-ene-3-beta-yl octanoate
einecs 214-656-2
unii-x9u26ha4z2
cholesteryl octanoate (caprylate)
SCHEMBL161053
AKOS024306975
SKLBBRQPVZDTNM-SJTWHRLHSA-N
5-cholesten-3.beta.-ol caprylate
cholest-5-en-3-ol (3.beta.)-, octanoate
3.beta.-octanoyloxycholest-5-ene
DTXSID00152038
J-003724
cholesterol n-caprylate
mfcd00003642
cholesteryl caprylate, united states pharmacopeia (usp) reference standard
(3s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-((r)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl octanoate
cholesterol caprylate
D95346
AS-57523
3.beta.-(octanoyloxy)cholest-5-ene
cholest-5-en-3-ol (3.beta.)-, 3-octanoate
cholesteryl caprylate [usp-rs]
caprylic acid cholesterol ester
cholesterol, octanoate
5-cholesten-3beta-ol 3-octanoate
CS-0185587
HY-W127349
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (13.33)18.7374
1990's9 (60.00)18.2507
2000's3 (20.00)29.6817
2010's1 (6.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.04 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.81 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (13.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (86.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]